📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
29 announcements match the current filters (relevance ≥ 5).
Sanstar to raise ₹198.27 Cr via 9% stake sale to Ingredion subsidiary; forms Joint Venture
Sanstar Limited has approved a significant fundraise of ₹198.27 crore through a preferential issue of 1.80 crore shares to Corn Products Development Inc., a subsidiary of the NYSE-listed global giant Ingredion Incorporated. The shares are priced at ₹110 each, representing a 9% stake in the company on a fully diluted basis. Alongside the capital infusion, Sanstar is entering a joint venture (Spark Ingredients Pvt Ltd) to expand into the pharmaceutical, nutraceutical, and personal care ingredient markets. The company is also increasing its authorized share capital from ₹38 crore to ₹50 crore to facilitate this transaction.
Key Highlights
Raising ₹198.27 crore by issuing 1,80,24,157 equity shares at ₹110 per share.
Strategic 9% stake acquisition by Corn Products Development Inc. (Ingredion subsidiary).
Formation of a Joint Venture, Spark Ingredients Private Limited, for pharma and food additives.
Authorized share capital increased from ₹38 crore to ₹50 crore.
Granting of special rights to the investor, including a nominee director seat and pre-emptive rights.
👀 What to Watch
This strategic partnership with a global leader like Ingredion is a major positive catalyst; investors should watch for the EGM approval on June 20, 2026, and subsequent JV execution.
Sanstar to raise ₹198.27 Cr from Ingredion subsidiary at ₹110/share for 9% stake
Sanstar Limited has approved a preferential issue of 1.80 crore shares to Corn Products Development Inc. (a subsidiary of NYSE-listed Ingredion Inc.) at ₹110 per share, totaling ₹198.27 crore. This strategic investment represents a 9% stake in the company and includes special rights such as board representation and affirmative voting. Furthermore, Sanstar is entering a joint venture, Spark Ingredients Private Limited, with Ingredion India to expand into pharmaceutical and food ingredient sectors. The board has also proposed increasing the authorized share capital from ₹38 crore to ₹50 crore to facilitate this growth.
Key Highlights
Raising ₹198.27 crore through the issuance of 1,80,24,157 equity shares at ₹110 each.
Strategic partnership with Ingredion Inc. (NYSE: INGR), a global leader in ingredient solutions.
Authorized share capital increased from ₹38 crore (19 crore shares) to ₹50 crore (25 crore shares).
Formation of a joint venture, Spark Ingredients Pvt Ltd, for pharma and food additive manufacturing.
Granting of special rights including one board nomination seat and pre-emptive rights to the investor.
👀 What to Watch
Investors should view this as a highly positive development as it brings in a global strategic partner at a premium to the floor price. Monitor the EGM on June 20, 2026, for final shareholder approval of these resolutions.
Sanstar FY26 Revenue at ₹7,846 Mn; Capacity Expands to 2,350 TPD
Sanstar reported a transition year in FY26 with revenues of ₹7,846 million, representing a 17.7% YoY decline due to H1 pricing pressures and maintenance shutdowns. However, Q4 FY26 showed a strong recovery with PAT margins improving to 9.5% and EBITDA growing 8.2% QoQ. The company successfully expanded its maize crushing capacity to 2,350 TPD, making it India's second-largest manufacturer in the segment. With a net cash position and the upcoming derivatives facility in FY27, the company is positioned for higher value-added product growth.
Key Highlights
Total installed capacity increased to 2,350 TPD following the Dhule facility expansion from 1,100 TPD.
FY26 Revenue stood at ₹7,846 Mn with a PAT of ₹345 Mn and a PAT margin of 4.4%.
Q4 FY26 PAT margins improved significantly to 9.5% from 6.8% in the previous quarter.
Net debt reduced to a negative ₹37 Mn, reflecting a strong cash-positive balance sheet and a Net Debt/Equity of -0.01x.
Derivatives facility at Dhule is expected to be commissioned in FY2026-27 to strengthen the high-value product portfolio.
👀 What to Watch
Investors should monitor the utilization ramp-up of the expanded Dhule facility and the timely commissioning of the high-margin derivatives unit in FY27. While Q4 shows recovery, global pricing competition in native starch remains a key risk factor to track.
Sanstar FY26 Revenue at ₹7,846 Mn; Capacity Expands to 2,350 TPD
Sanstar reported a transition year in FY26 with annual revenue declining 17.7% YoY to ₹7,846 million, primarily due to maintenance shutdowns and pricing pressure from Chinese exports. However, Q4 FY26 showed a strong recovery with revenue growing 7.4% QoQ to ₹2,168 million and PAT margins improving significantly to 9.5%. The company successfully commissioned its Dhule expansion, reaching a total capacity of 2,350 TPD, making it India's second-largest maize-based specialty products manufacturer. Debt levels were further reduced, resulting in a healthy net debt-to-equity ratio of (0.01)x.
Key Highlights
FY26 Revenue stood at ₹7,846 million, while Q4 FY26 Revenue grew 7.4% QoQ to ₹2,168 million.
Q4 PAT margin improved to 9.5% from 6.8% in the previous quarter, despite annual EBITDA margins being 4.8%.
Total installed capacity increased to 2,350 TPD following the successful expansion at the Dhule facility.
Total debt reduced to ₹199 million from ₹271 million, with a net debt-to-equity ratio of (0.01)x.
Derivatives facility at Dhule is on track to be commissioned in FY2026-27 to enhance the value-added product mix.
👀 What to Watch
Investors should monitor the utilization levels of the newly expanded capacity and the stabilization of global starch prices. The upcoming commissioning of the derivatives facility in FY27 is a key catalyst for margin expansion.
Sanstar Q4 Net Profit Surges to ₹20.49 Cr Despite Yearly Revenue Decline
Sanstar Limited reported a strong recovery in Q4 FY26 net profit, reaching ₹20.49 crore compared to ₹1.52 crore in the same quarter last year. However, the full-year performance showed a decline, with annual revenue falling from ₹957.45 crore in FY25 to ₹784.63 crore in FY26. A key positive is the sharp reduction in finance costs, which dropped from ₹7.53 crore to ₹1.37 crore annually, indicating improved debt management. The board also approved the appointment of new internal and secretarial auditors for the upcoming financial year.
Key Highlights
Q4 FY26 Net Profit rose significantly to ₹20.49 crore from ₹1.52 crore in Q4 FY25
Annual Revenue for FY26 decreased by 18% to ₹784.63 crore from ₹957.45 crore in FY25
Full-year Net Profit for FY26 stood at ₹34.45 crore, down from ₹43.80 crore in the previous year
Finance costs saw a massive reduction of 81.8%, falling to ₹1.37 crore for the full year
The company reported an unmodified audit opinion for the financial year ended March 31, 2026
👀 What to Watch
Investors should monitor the company's ability to arrest the revenue decline while maintaining the improved margins seen in Q4. The significant reduction in finance costs is a positive sign of balance sheet strengthening.
Sanstar Commissions Dhule Capacity Expansion; Total Capacity Reaches 2,350 TPD
Sanstar Limited has successfully commissioned its expanded native starch manufacturing capacity at the Dhule facility, doubling its total installed capacity from 1,100 TPD to 2,350 TPD. The project fully utilized Rs. 1,816 million of IPO proceeds and exceeded the original expansion target of 1,000 MTPD by achieving 1,250 MTPD. While the native starch phase is now operational, the high-value derivatives facility is expected to be commissioned in FY2026-27. This expansion positions Sanstar as the second-largest maize-based specialty products manufacturer in India.
Key Highlights
Total installed capacity increased significantly from 1,100 TPD to 2,350 TPD
Fully utilized Rs. 1,816 million of IPO proceeds for the Dhule facility expansion
Achieved 1,250 MTPD capacity addition, exceeding the initial IPO plan of 1,000 MTPD
Derivatives facility phase is on track for commissioning within FY2026-27
Strategic location in Dhule offers logistical advantages for both domestic sourcing and exports
👀 What to Watch
Investors should monitor the capacity utilization rates and revenue growth in the coming quarters as the new capacity ramps up. The upcoming derivatives facility in FY27 will be a critical driver for margin expansion through value-added products.
Sanstar Limited Credit Rating Reaffirmed at 'BBB+; Stable' for ₹113.75 Crore Bank Facilities
CARE Ratings has reaffirmed Sanstar Limited's credit ratings for its bank facilities totaling ₹113.75 crore. The long-term and short-term facilities of ₹95.00 crore were reaffirmed at CARE BBB+; Stable / CARE A2, while specific short-term facilities of ₹18.75 crore were reaffirmed at CARE A2. The review was based on the company's audited operational and financial performance for FY25 and the first nine months of FY26. This reaffirmation indicates a consistent credit profile and stable financial outlook for the company.
Key Highlights
CARE Ratings reaffirmed 'CARE BBB+; Stable / CARE A2' for ₹95.00 crore in long-term/short-term bank facilities.
Short-term bank facilities amounting to ₹18.75 crore were reaffirmed at 'CARE A2'.
The total bank facilities covered under this rating action amount to ₹113.75 crore.
Ratings were reviewed based on audited financial performance for FY25 and 9MFY26.
The 'Stable' outlook suggests that the company is expected to maintain its credit profile in the medium term.
👀 What to Watch
Investors should take this as a sign of financial stability as the company has maintained its creditworthiness. No immediate action is required, but a future upgrade would be a positive signal for lower borrowing costs.
Sanstar Q3 FY26 PAT Recovers to ₹137 Mn; Dhule Expansion to Commission in Feb 2026
Sanstar Limited reported a sequential recovery in Q3 FY26 with revenue of ₹2,018 million and a PAT of ₹137 million, following a volatile first half. EBITDA margins improved significantly to 8.9% in Q3 from a low of 0.7% in Q2, driven by higher plant utilization and better cost control. However, 9M FY26 performance remains subdued with revenue down 22.3% YoY to ₹5,679 million due to pricing pressure from Chinese exports in Southeast Asia. The company's major capacity expansion at Dhule is on track, with the native starch plant expected to commission by late February 2026.
Key Highlights
Q3 FY26 Revenue stood at ₹2,018 million, reflecting a 2.7% sequential growth over Q2.
EBITDA recovered to ₹179 million in Q3 from ₹14 million in Q2, with margins reaching 8.9%.
9M FY26 Revenue declined 22.3% YoY to ₹5,679 million, impacted by global pricing headwinds.
Dhule expansion to 2,100 TPD is nearing completion, with the native starch unit set for Q4 FY26 commissioning.
Exports contributed ₹644 million to Q3 revenue, serving 58 countries despite Chinese competition.
👀 What to Watch
Investors should focus on the successful commissioning and ramp-up of the Dhule expansion in Q4 FY26, which is critical for future volume growth. While sequential recovery is positive, the impact of Chinese export intensity on global starch realizations remains a key risk to monitor.
Sanstar Q3 FY26 Net Profit at ₹13.67 Cr; Sequential Recovery but 9M Profit Down 63% YoY
Sanstar Limited reported a strong sequential recovery in the quarter ended December 31, 2025, with net profit rising to ₹13.67 crore from a low of ₹0.63 crore in Q2 FY26. However, the year-on-year performance remains weak, with Q3 revenue declining 8.9% to ₹201.76 crore. For the nine-month period (9M FY26), net profit has fallen sharply to ₹13.96 crore compared to ₹38.28 crore in the previous year. On a positive note, finance costs have reduced significantly following the repayment of ₹100 crore in borrowings using IPO proceeds.
Key Highlights
Net Profit for Q3 FY26 stood at ₹13.67 crore, recovering from ₹0.63 crore in the previous quarter.
Revenue from operations for Q3 FY26 was ₹201.76 crore, down from ₹221.42 crore in Q3 FY25.
9M FY26 Net Profit dropped to ₹13.96 crore from ₹38.28 crore in 9M FY25, a 63.5% decline.
Finance costs for 9M FY26 decreased to ₹1.72 crore from ₹6.72 crore YoY due to debt repayment.
Company has utilized ₹357.23 crore of IPO proceeds, with ₹181.56 crore spent on the Dhule plant expansion.
👀 What to Watch
While the sequential recovery in margins is encouraging, the significant year-on-year decline in 9M profitability warrants caution. Investors should monitor the impact of the Dhule plant expansion on future revenue growth.
